In the literature, it has been shown that NF-κB activation promotes inflammation-mediated tumor cell survival and progression [54] and blocking NF-κB activation can convert inflammation-induced tumor progression mediated by TNFα to TRAIL-mediated tumor regression in an experimental metastasis mouse model [55]. The gene discussed is TNFSF10; the disease is neoplasm.